DA Davidson Maintains Buy on Cellebrite DI, Raises Price Target to $22
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.